Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016 (2016), Article ID 1638916, 11 pages
http://dx.doi.org/10.1155/2016/1638916
Research Article

Negative Impact of Hypoxia on Tryptophan 2,3-Dioxygenase Function

1Institute of Medical Microbiology and Hospital Hygiene, Heinrich-Heine-University, 40225 Düsseldorf, Germany
2Center for Advanced Research and Education, Asahikawa Medical University, Asahikawa 078-8510, Japan
3Neurogen Inc., 1-1-52-201 Nakahozumi, Ibaraki 567-0034, Japan
4Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Institute of Epidemiology, 17493 Greifswald-Insel Riems, Germany

Received 31 March 2016; Revised 14 June 2016; Accepted 26 June 2016

Academic Editor: José César Rosa Neto

Copyright © 2016 Frank Elbers et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Wiese, R. G. Gerlach, I. Popp et al., “Hypoxia-mediated impairment of the mitochondrial respiratory chain inhibits the bactericidal activity of macrophages,” Infection and Immunity, vol. 80, no. 4, pp. 1455–1466, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. G. K. Wilson, D. A. Tennant, and J. A. McKeating, “Hypoxia inducible factors in liver disease and hepatocellular carcinoma: current understanding and future directions,” Journal of Hepatology, vol. 61, no. 6, pp. 1397–1406, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. A. P. Araújo, T. F. Frezza, S. M. Allegretti, and S. Giorgio, “Hypoxia, hypoxia-inducible factor-1α and vascular endothelial growth factor in a murine model of Schistosoma mansoni infection,” Experimental and Molecular Pathology, vol. 89, no. 3, pp. 327–333, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. S. K. Schmidt, A. Müller, K. Heseler et al., “Antimicrobial and immunoregulatory properties of human tryptophan 2,3-dioxygenase,” European Journal of Immunology, vol. 39, no. 10, pp. 2755–2764, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Bessede, M. Gargaro, M. T. Pallotta et al., “Aryl hydrocarbon receptor control of a disease tolerance defence pathway,” Nature, vol. 511, no. 7508, pp. 184–190, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. N. van Baren and B. J. van den Eynde, “Tumoral immune resistance by enzymes that degrade tryptophan,” Cancer Immunology Research, vol. 3, pp. 978–985, 2015. View at Publisher · View at Google Scholar
  7. N. van Baren and B. J. Van den Eynde, “Tryptophan-degrading enzymes in tumoral immune resistance,” Frontiers in Immunology, vol. 6, article 34, pp. 1–9, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Pilotte, P. Larrieu, V. Stroobant et al., “Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 7, pp. 2497–2502, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. C. A. Opitz, U. M. Litzenburger, F. Sahm et al., “An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor,” Nature, vol. 478, no. 7368, pp. 197–203, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Collet, B. E. Hafny-Rahbi, M. Nadim, A. Tejchman, K. Klimkiewicz, and C. Kieda, “Hypoxia-shaped vascular niche for cancer stem cells,” Contemporary Oncology, vol. 19, pp. 39–43, 2015. View at Publisher · View at Google Scholar
  11. M. C. Krishna, S. Matsumoto, K. Saito, M. Matsuo, J. B. Mitchell, and J. H. Ardenkjaer-Larsen, “Magnetic resonance imaging of tumor oxygenation and metabolic profile,” Acta Oncologica, vol. 52, no. 7, pp. 1248–1256, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Jantsch and J. Schödel, “Hypoxia and hypoxia-inducible factors in myeloid cell-driven host defense and tissue homeostasis,” Immunobiology, vol. 220, no. 2, pp. 305–314, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Schaffer and C. T. Taylor, “The impact of hypoxia on bacterial infection,” The FEBS Journal, vol. 282, no. 12, pp. 2260–2266, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Däubener, N. Wanagat, K. Pilz, S. Seghrouchni, H. G. Fischer, and U. Hadding, “A new, simple, bioassay for human IFN-γ,” Journal of Immunological Methods, vol. 168, no. 1, pp. 39–47, 1994. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Moreau, J. Lestage, D. Verrier et al., “Bacille Calmette-Guérin inoculation induces chronic activation of peripheral and brain indoleamine 2,3-dioxygenase in mice,” Journal of Infectious Diseases, vol. 192, no. 3, pp. 537–544, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. C. R. MacKenzie, U. Hadding, and W. Däubener, “Interferon-γ-induced activation of indoleamine 2,3-dioxygenase in cord blood monocyte-derived macrophages inhibits the growth of group B streptococci,” Journal of Infectious Diseases, vol. 178, no. 3, pp. 875–878, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Spekker, M. Leineweber, D. Degrandi et al., “Antimicrobial effects of murine mesenchymal stromal cells directed against Toxoplasma gondii and Neospora caninum: role of immunity-related GTPases (IRGs) and guanylate-binding proteins (GBPs),” Medical Microbiology and Immunology, vol. 202, no. 3, pp. 197–206, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Kanai, H. Funakoshi, H. Takahashi et al., “Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice,” Molecular Brain, vol. 2, no. 1, article 8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. S. K. Schmidt, S. Ebel, E. Keil et al., “Regulation of IDO activity by oxygen supply: inhibitory effects on antimicrobial and immunoregulatory functions,” PLoS ONE, vol. 8, no. 5, Article ID e63301, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Song, H. Li, L. Yang, Y. Lei, L. Yao, and H. Wen, “Expression of hypoxia-inducible factor-1α in the infiltrative belt surrounding hepatic alveolar echinococcosis in rats,” Journal of Parasitology, vol. 101, no. 3, pp. 369–373, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Mahnke, R. J. Meier, V. Schatz et al., “Hypoxia in leishmania major skin lesions impairs the NO-dependent leishmanicidal activity of macrophages,” Journal of Investigative Dermatology, vol. 134, no. 9, pp. 2339–2346, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. O. Hayaishi, S. Rothberg, A. H. Mehler, and Y. Saito, “Studies on oxygenases. Enzymatic formation of kynurenine from tryptophan,” The Journal of Biological Chemistry, vol. 229, no. 2, pp. 889–896, 1957. View at Google Scholar · View at Scopus
  23. E. R. Pfefferkorn, “Inhibition of growth of Toxoplasma gondii in cultured fibroblasts by human recombinant gamma interferon,” Infection and Immunity, vol. 44, pp. 211–216, 1984. View at Google Scholar
  24. C. R. MacKenzie, K. Heseler, A. Müller, and W. Däubener, “Role of indoleamine 2,3-dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynurenines,” Current Drug Metabolism, vol. 8, no. 3, pp. 237–244, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Lu, Y. Lin, and S.-R. Yeh, “Inhibitory substrate binding site of human indoleamine 2,3-dioxygenase,” Journal of the American Chemical Society, vol. 131, no. 36, pp. 12866–12867, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Roth, P. König, V. G. Zandbergen et al., “Hypoxia abrogates antichlamydial properties of IFN-γ in human fallopian tube cells in vitro and ex vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 45, pp. 19502–19507, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Hu and L. Li, “In vitro culture of isolated primary hepatocytes and stem cell-derived hepatocyte-like cells for liver regeneration,” Protein and Cell, vol. 6, no. 8, pp. 562–574, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. K. R. Atkuri, L. A. Herzenberg, and L. A. Herzenberg, “Culturing at atmospheric oxygen levels impacts lymphocyte function,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 10, pp. 3756–3759, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Yang, L. Jiang, H. Zhang, L. A. Shimoda, R. J. Deberardinis, and G. L. Semenza, “Analysis of hypoxia-induced metabolic reprogramming,” Methods in Enzymology, vol. 542, pp. 425–455, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Zhu and H. F. Bunn, “Oxygen sensing and signaling: impact on the regulation of physiologically important genes,” Respiration Physiology, vol. 115, no. 2, pp. 239–247, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. V. Nizet and R. S. Johnson, “Interdependence of hypoxic and innate immune responses,” Nature Reviews Immunology, vol. 9, no. 9, pp. 609–617, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Palazon, A. W. Goldrath, V. Nizet, and R. S. Johnson, “HIF transcription factors, inflammation, and immunity,” Immunity, vol. 41, no. 4, pp. 518–528, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Bhandari and V. Nizet, “Hypoxia-inducible factor (HIF) as a pharmacological target for prevention and treatment of infectious diseases,” Infectious Diseases and Therapy, vol. 3, no. 2, pp. 159–174, 2014. View at Publisher · View at Google Scholar
  34. B. Schaible, S. McClean, A. Selfridge et al., “Hypoxia modulates infection of epithelial cells by Pseudomonas aeruginosa,” PLoS ONE, vol. 8, no. 2, article e56491, 2013. View at Publisher · View at Google Scholar · View at Scopus